SEARCH

Health » Policy & Issues

Updated: July 4, 2013 21:08 IST

Govt mulling ban on sale of TB drugs in open market

PTI
Comment (2)   ·   print   ·   T  T  
A protest in Mumbai against the developed countries move to block access to HIV and TB drugs.
BL
A protest in Mumbai against the developed countries move to block access to HIV and TB drugs.

Sale of tuberculosis drugs could be prohibited in open market as part of efforts to ensure calibrated and monitored administration of these medicines which would then only be given on daily basis free of cost by government registered outlets to patients.

The Health Ministry is proposing changes in view of irregularity in administration of these drugs to patients and lack of proper monitoring which is hindering efforts to check the disease, sources told PTI.

According to a WHO estimate, India is home to the largest number of TB patients - 2.2 million of the world’s 8.7 million.

Patients are administered TB medicines either through government-run hospitals and clinics free of cost or by private practitioners.

According to the Health Ministry, about 65 per cent of the TB patients avail these drugs under the government’s DOT (Daily Observed Therapy) System while the rest opt for treatment by private practitioners and buy drugs from the chemists based on their prescription.

The latter results in irregularity of treatment which leads to relapse of the ailment as there is lack of proper monitoring, the sources said citing experts.

To address this, the government is planning to prohibit sale of drugs in open market.

Under the new initiative, patients going to private practitioners for treatment will get medicines free of cost from chemists but only after the doctor informs them through a dedicated call centre to be set up by the government.

The changes are being brought to ensure that all TB patients are administered the drugs on daily basis instead of intermittently as at present.

Recently, Health Minister Gulam Nabi Azad had expressed concern on the issue saying that the irregular regime is leading to growing resistance to anti-TB drugs.

The Health Ministry officials recently had held a meeting with WHO and other experts who had emphasised on changing intermittent dosage system to daily regime.

During the meeting, it was informed that many other countries including Brazil, China, which were following the intermittent dosage system, have now turned to daily regime.

Novartis has been providing First World medicines to a third world country like India and so we should support them for this noble deed.

from:  sundaram padmanabhan
Posted on: Jul 6, 2013 at 07:18 IST

The intermittent dose method was initiated by RNTCP approved by WHO.But most of the private practitioners always prescribe daily dosage method which has been giving good results.It is proved practically that the intermittent dosage is resulting drug resistance.Atleast now the government has realised the wrong prescription dosage method.

from:  JP Reddy
Posted on: Jul 5, 2013 at 08:13 IST
This article is closed for comments.
Please Email the Editor
Group Sites
The Hindu தி இந்து Business Line Sportstar Frontline The Hindu Centre The Hindu Hub Images Classifieds RoofandFloor

O
P
E
N

close

Recent Article in Policy & Issues

Health Hub: No to ‘low sugar’ episodes

For a diabetic on insulin or other drugs that lower the blood sugar level, the dangers of hypoglycemia are always there. »